Page last updated: 2024-12-08

stenbolone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

stenbolone: structure given in first source; RN given from Merck; RN given refers to the (5alpha,17beta)-isomer; RN for cpd without isomeric designation not available 7/91 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID234454
CHEBI ID34980
SCHEMBL ID145680
MeSH IDM0188669

Synonyms (31)

Synonym
stenbolonum [inn-latin]
estembolona [inn-spanish]
estembolona
stenbolone [inn]
17beta-hydroxy-2-methyl-5alpha-androst-1-en-3-on
nsc 65890
androst-1-en-3-one, 17-hydroxy-2-methyl-, (5alpha,17beta)-
3q6fka848s ,
unii-3q6fka848s
nsc 34418
stenbolonum
nsc-34418
nsc34418
deacetylanatrofin
5197-58-0
stenbolone
5.alpha.-androst-1-en-3-one, 17.beta.-hydroxy-2-methyl-
LMST02020044
17beta-hydroxy-2-methyl-5alpha-androst-1-en-3-one
nsc65890
nsc-65890
(5s,8r,9s,10s,13s,14s,17s)-17-hydroxy-2,10,13-trimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
stenbolone [mart.]
stenbolone [mi]
17.beta.-hydroxy-2-methyl-5.alpha.-androst-1-en-3-one
SCHEMBL145680
CS-4516
CHEBI:34980
HY-16971
DTXSID70199935
Q7607492
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
androgenA sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
3-hydroxy steroidAny hydroxy steroid carrying a hydroxy group at position 3.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.28 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index73.99 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (20.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]